U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503444) titled 'A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome' on March 25.
Brief Summary: The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Rett Syndrome
Intervention:
DRUG: fenfluramine hydrochloride
Oral solution
OTHER: Placebo
Oral solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: UCB BIOSCIENCES, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....